Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Tender notice |
| Buyer: | MHRA |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: |
| Open |
| Estimated Value (ex. VAT): | £1,200,000 |
| Estimated Value (inc. VAT): | £1,400,000 |
| Release Date: | 11 September 2026 |
| Application Deadline: | 13 October 2026 |
| Enquiry Deadline: | 2 October 2026 |
| Contract Start Date: | 10 November 2026 (Estimated) |
| Contract End Date: | 9 November 2031 (Estimated) |
| Contract Duration: | 5.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-06f7b3 |
| Notice Reference: | 086256-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
The MHRA has a requirement to award a contract for The Provision and Maintenance of Two Mass Spectrometry systems to one Tenderer as replacements of two Triple Quad Mass Spectrometers (s/n TQH-Q1-0526 and TQH-Q1-0525) for quantification and characterisation of biological medicine standards, including influenza, and to support counterfeit and sub-potent medicine characterisation. These systems are to be purchased with service maintenance and any bespoke consumables required to run the systems as follows: System 1. A high-resolution mass spectrometer coupled with a low flow liquid chromatography (LC) system (hereinafter referred to as a “high resolution mass spectrometry system” or “HRMS system”). The system should include all the instrumentation and software to allow qualitative and quantitative analysis of samples in a wide range of complex biological matrices in the areas of proteomics, intact protein analysis, biopharmaceutical characterisation, e.g. multi-attribute monitoring of therapeutic antibodies, post-translational modifications and small molecules/metabolomics as well as glycoproteins and oligonucleotides (OGNs). System 2. A triple quadrupole mass spectrometer coupled with an ultra-high performance liquid chromatography (UPLC) (hereinafter referred to as a “triple quad MS system”). The system should include all the instrumentation and software to allow for high throughput targeted quantitative analysis across biopharma, clinical and small molecule applications, supporting large SRM/MRM panels.
Document pack· 1 file
Published contracts in the last 12 months
99
total contracts
£55.5m
total value
£1,322,214
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
13 October 2026
29 days left
Estimated Value
£1,200,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →